trending Market Intelligence /marketintelligence/en/news-insights/trending/k_nqeyw7r9k916fpwvg2ra2 content esgSubNav
In This List

Teva taps senior VP to lead generic-drug unit

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Teva taps senior VP to lead generic-drug unit

Teva Pharmaceutical Industries Ltd. has appointed John Nason to lead its Teva Active Pharmaceutical Ingredients unit, the leading global provider of active pharmaceutical ingredients.

As president, Nason will oversee the Teva unit that manufactures generic drugs and a portfolio of specialty medicines. He will be based in Teva's global headquarters in Petach Tikva, Israel.

Nason has worked for Teva since 2015 as senior vice president of European technical operations. According to the company's Sept. 5 statement, he worked at Bristol-Myers Squibb Co. for 12 years prior to his time with Teva.